TECH
Bio-Techne Corp
NASDAQ: TECH · HEALTHCARE · BIOTECHNOLOGY
$72.69
+0.12% today
Updated 2026-10-28
Market cap
$11.38B
P/E ratio
62.56
P/S ratio
9.37x
EPS (TTM)
$1.16
Dividend yield
0.44%
52W range
$43 – $73
Volume
2.8M
Bio-Techne Corp (TECH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$72.69
12-Month target
$11.32
2030 Target
—
Intrinsic (DCF)
$194.44
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $1.3B | $1.4B | $1.4B | $1.5B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 5.47% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 15.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.